Physician profile
Brian Michael Ware
NPI 1578990875
$2,234.47
in general payments reported to CMS, 2019-2025
24 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.55 · 2022: $557 · 2023: $648 · 2024: $691 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,666.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $392.07 | 2022-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $320.30 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals Lp | $305.74 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $260.80 | 2022-2024 | |
| Novo Nordisk INC | $196.70 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $95.38 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $93.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.65 | 2024-2025 | |
| Amgen INC. | $68.07 | 2022-2024 | Evenity, Prolia, Otezla |
| Pfizer INC. | $50.49 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.17 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $34.59 | 2024 | Fanapt |
| Inari Medical, INC. | $34.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.87 | 2023-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $30.53 | 2023-2025 | Trintellix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $27.38 | 2024 | Auvelity |
| Exact Sciences Corporation | $26.85 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $24.26 | 2023 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $21.31 | 2025 | Rexulti |
| Abbott Laboratories | $18.26 | 2024 | Freestyle Libre 3 |
| Corium, LLC | $16.43 | 2025 | Azstarys |
| Phathom Pharmaceuticals, INC. | $15.87 | 2025 | Voquezna |
| Astellas Pharma US INC | $14.97 | 2024 | Veozah |
| Baxter Healthcare | $14.72 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.